The statistic shows the revenue of Takeda Pharmaceutical Co. , Ltd. in fiscal year 2016 , broken down by segment . That year , the prescription drug segment of the Japanese pharmaceutical company Takeda generated a revenue of approximately 1.57 trillion Japanese yen , whereas the consumer healthcare segment 's revenue amounted to around 82.57 billion yen . With changes in the company structure in April 2017 the company has reconsidered its segment structure and concluded that Takeda comprises one operating segment : pharmaceutical products . Hence , from fiscal year 2017 onwards the revenue breakdown by segment will no longer be reported .
